Recent News

• 09.08.2025 - Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
• 09.02.2025 - Medicus Pharma Ltd. Completes Acquisition of Antev Limited
• 08.21.2025 - Medicus Pharma Ltd. Provides Update on Doxorubicin Containing Novel Microneedle Array (D-MNA) Clinical Development Program for the Treatment of Basal Cell Carcinoma (BCC) of the Skin and Reports Second Quarter 2025 Financial Highlights

Recent Filings

• 09.08.2025 - 3 Initial statement of beneficial ownership of securities
• 09.02.2025 - EX-99.1 EX-99.1
• 09.02.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 09.02.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 09.02.2025 - 8-K Current report
• 09.02.2025 - 253G2 253G2
• 09.02.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 08.22.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 08.22.2025 - 253G2 253G2
• 08.22.2025 - 424B3 Prospectus [Rule 424(b)(3)]